Sökning: "Carl Johan Östgren"

Visar resultat 1 - 5 av 16 avhandlingar innehållade orden Carl Johan Östgren.

  1. 1. Leptin and the Intersection of Cardiovascular Disease, Metabolism, and Adipose Tissue

    Författare :Camilla Vavruch; Fredrik Nyström; Carl Johan Östgren; Johan Ärnlöv; Kristina Boström; Linköpings universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Leptin; Type 2 diabetes mellitus; Adipose tissue; Cardiovascular disease; Metabolism; Cardiovascular risk factors;

    Sammanfattning : According to the World Health Organization, cardiovascular disease (CVD) is a group of disorders of the heart and blood vessels, and it is the leading cause of death worldwide. The risk factors for CVD are divided into two major classes: non-modifiable (age, gender, family history) and modifiable (including tobacco use, type 2 diabetes mellitus (T2DM), physical inactivity, unhealthy diet, abdominal obesity, high cholesterol, dyslipidemia, and stress). LÄS MER

  3. 2. Type 2 Diabetes in a Defined Population The Skaraborg Hypertension and Diabetes Project

    Författare :Carl Johan Östgren; Malmö Institutionen för kliniska vetenskaper; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Endocrinology; HOMA; primary care; all-cause mortality; Pro12Ala; PPAR-gamma; survival; insulin resistance; beta-cell function; type 2 diabetes; hypertension; secreting systems; diabetology; Endokrinologi; sekretion; diabetologi;

    Sammanfattning : To examine cardiovascular risk factors, glycaemic control and survival in patients with type 2 diabetes mellitus (T2DM) treated in primary care, patients with T2DM and a randomised age-stratified sample of men and women aged ≥40 years living in the same community were surveyed 1992-1994. ß–Cell function and insulin resistance were estimated using the Homeostasis Model Assessment (HOMA). LÄS MER

  4. 3. Markers of subclinical atherosclerosis and arterial stiffness in type 2 diabetes

    Författare :Elsa Dahlén; Carl Johan Östgren; Toste Länne; Fredrik Nyström; Lars Lind; Linköpings universitet; []
    Nyckelord :MEDICINE; MEDICIN;

    Sammanfattning : Background: Type 2 diabetes is a common disease with increased mortality and morbidity due to cardiovascular disease (CVD). This thesis is based on three studies that evaluated traditionally used and emerging risk markers to identify individuals with high-risk of developing CVD in middle-aged men and women with type 2 diabetes. LÄS MER

  5. 4. Risk factors in type 2 diabetes with emphasis on blood pressure, physical activity and serum vitamin D

    Författare :Pär E:son Jennersjö; Carl Johan Östgren; Fredrik Nyström; Toste Länne; Mai-Lis Hellénius; Linköpings universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES;

    Sammanfattning : BackgroundType 2 diabetes is a common chronic disease with a two-fold increased risk for cardiovascular morbidity and mortality and has an increasing prevalence worldwide. This thesis is based on a study conducted in primary health care in Östergötland and Jönköping, Sweden. LÄS MER

  7. 5. Treatment of cardiovascular risk factors in type 2 diabetes : time trends and clinical practice

    Författare :Eva Fhärm; Olov Rolandsson; Eva Johansson; Lars Weinehall; Carl-Johan Östgren; Umeå universitet; []
    Nyckelord :diabetes mellitus; cardiovascular disease; effectiveness; epidemiology; guideline adherence; primary health care; risk factor;

    Sammanfattning : Objectives Patients with type 2 diabetes are at much greater risk of developing cardiovascular diseases (CVD), including coronary heart disease (CHD), compared to non-diabetics. The lowering of glucose, blood pressure, and plasma lipid levels has been shown to reduce CHD risk, and treatment goals for these risk factors are now part of clinical practice guidelines. LÄS MER